Clin2
NCT06473766Likely a fitRecruiting

Ultrasound data to tell benign from malignant ovarian masses

Ovarian Cancer

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study uses ultrasound data to help tell the difference between benign (non-cancerous) and malignant (cancerous) solid ovarian masses. It may help improve diagnosis and treatment decisions for people with this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have an ultrasound finding of a solid ovarian mass (at least 80% solid tissue).
  • You are planning surgery to remove the mass within 120 days of the ultrasound.
  • You are 18 years old or older.
  • You are willing to sign a consent form to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06635837Recruiting
MRI for ovarian masses during pregnancy

This study looks at whether MRI can help doctors better understand ovarian masses found during pregnancy. It aims to improve diagnosis and care for you and your baby.

Rome
NCT06103916Recruiting
Testing the ADNEX model for ovarian tumors

This trial is testing how well a special ultrasound model (ADNEX) can predict whether an ovarian tumor is benign or cancerous. It helps doctors make better decisions, and it’s for people with complex ovarian tumors who speak Dutch.

Veldhoven, North Brabant
NCT05842629Recruiting
Better ways to diagnose ovarian cancer

This study focuses on improving diagnosis of ovarian cancer. If you have an abnormal mass seen on ultrasound near the ovaries, the researchers may evaluate how best to identify whether it could be ovarian cancer.

Aarhus
NCT05931055Not yet recruiting
Blood test to spot early ovarian cancer risk

This trial checks whether a “liquid biopsy,” a blood test, can help doctors tell apart different causes of a suspicious pelvic/ovarian mass and help with early detection. It may help avoid uncertainty before surgery by adding test results from blood along with imaging and standard markers.

NCT05769517Recruiting
Using ultrasound to predict BRCA genes from healthy ovaries

This study looks at whether pictures from a vaginal (transvaginal) ultrasound of a healthy ovary can help predict whether someone carries BRCA1 or BRCA2 gene changes. It may help identify people who could benefit from more genetic testing, without needing new ultrasound images.

Rome
NCT06817174Recruiting
CT scan analysis for ovarian cancer treatment planning

This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.

London

Hear when a new Ovarian cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.